Epigenetic age acceleration of early stage hepatocellular carcinoma tightly associated with hepatitis B virus load, immunoactivation, and improved survival-Reference-Cited by-同舟云学术

Epigenetic age acceleration of early stage hepatocellular carcinoma tightly associated with hepatitis B virus load, immunoactivation, and improved survival

Published:2020-09-11 Issue:10 Volume:21 Page:899-906
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Fan Xiaole¹,Yuan Hongxin¹,Zhao Suming¹,Yang Xiaohu¹,Shi Rongfeng¹,Wang Jingli¹,Zhao Hui¹^ORCID

Affiliation:

1. Department of Interventional Radiology, The Affiliated Hospital of Nantong University; Medical School of Nantong University, Nantong, Jiangsu, P.R. China

Funder

Standardized Treatment of Acute Lower Extremity Deep Venous Thrombosis

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2020.1804284

Reference47 articles.

1. Hepatocellular Carcinoma

2. Cancer statistics, 2019

3. Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recalibrate concepts of epigenetic aging clocks in human health;Aging;2024-07-17

2. Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-02-08

3. Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma;Hepatology International;2022-09-20

4. Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma;Cancer Cell International;2021-09-06